Bill Text: OR HB3140 | 2013 | Regular Session | Introduced

Oregon House Bill 3140 (Prior Session Legislation)

Bill Title: Relating to screening infants for controlled substances.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Failed) 2013-07-08 - In committee upon adjournment. [HB3140 Detail]

Download: Oregon-2013-HB3140-Introduced.html



     77th OREGON LEGISLATIVE ASSEMBLY--2013 Regular Session

NOTE:  Matter within  { +  braces and plus signs + } in an
amended section is new. Matter within  { -  braces and minus
signs - } is existing law to be omitted. New sections are within
 { +  braces and plus signs + } .

LC 3487

                         House Bill 3140

Sponsored by Representative KENY-GUYER

                             SUMMARY

The following summary is not prepared by the sponsors of the
measure and is not a part of the body thereof subject to
consideration by the Legislative Assembly. It is an editor's
brief statement of the essential features of the measure as
introduced.

  Requires Oregon Health Authority to adopt rules requiring
hospitals and freestanding birthing centers, depending on number
of live births performed at hospital or freestanding birth center
each year, to screen infants for controlled substances or notify
parents or legal guardians of importance of screening infants for
controlled substances.

                        A BILL FOR AN ACT
Relating to screening infants for controlled substances.
Be It Enacted by the People of the State of Oregon:
  SECTION 1.  { + (1) As used in this section:
  (a) 'Freestanding birthing center' has the meaning given that
term in ORS 442.015.
  (b) 'Hospital' has the meaning given that term in ORS 442.015.
  (c) 'Live birth' has the meaning given that term in ORS
432.005.
  (2) The Oregon Health Authority shall adopt rules requiring:
  (a) Except as provided in subsection (3) of this section, a
hospital or freestanding birthing center at which 200 or more
live births are performed each year to screen the infant that is
the product of the live birth for controlled substances that
entered the bloodstream of the infant while the infant was in
utero before discharging the infant; and
  (b) A hospital or freestanding birthing center at which fewer
than 200 live births are performed each year to provide notice to
a parent or legal guardian of the infant that is the product of
the live birth of the importance of screening the infant for
controlled substances that entered the bloodstream of the infant
while the infant was in utero before discharging the infant.
  (3) The authority may adopt rules by which a hospital or
freestanding birthing center that is subject to subsection (2)(a)
of this section may screen an infant after discharging the infant
if:
  (a) The hospital or freestanding birthing center cannot
reasonably screen the infant before discharging the infant; and
  (b) The hospital or freestanding birthing center makes an
appointment to screen the infant no later than one month from the
date of live birth.
  (4) Rules adopted under subsection (2)(a) of this section must
prohibit the disclosure of personally identifiable information
related to the screening of an infant except:
  (a) For purposes related to diagnosing or treating the infant;
or
  (b) To a parent or legal guardian of the infant. + }
                         ----------